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Abstract 27 
Growing evidence points to an association between timing of food intake and obesity in humans, raising the 28 
question if when to eat matters as much as what and how much to eat. Based on the new definition of obesity 29 
as a chronobiological disease, an unusual or late meal timing represent a circadian chronodisruption, leading 30 
to metabolic impairments.  31 
Preliminary data from cross-sectional and experimental studies suggest that changes in meal timing can 32 
influence obesity and success of weight loss therapy, independently from total energy intake, dietary 33 
composition and estimated energy expenditure. 34 
A systematic review of observational and experimental studies in humans was conducted to explore the link 35 
between time of food ingestion, obesity and metabolic alterations. Results confirm that eating time is relevant 36 
for obesity and metabolism: observational and experimental studies found an association between meal 37 
timing, weight gain, hyperglycemia and diabetes mellitus with benefits deriving from an early intake of food 38 
in the day in a wide range of individuals. Herein clinical, future perspectives of chronoprevention and 39 
chronotherapy of obesity and type 2 diabetes are also provided. 40 
In conclusion, meal timing appears as a new potential target in weight control strategies, and therapeutic 41 
strategies should consider this contributor in the prevention of obesity. 42 
 43 
 44 
1. Introduction 45 
In the last decade, a new relevant question has arisen: when to eat [1-3]. In addition to what and how much 46 
to eat, food timing represents a novel issue in our 24-h modern society, characterized by more exposure to 47 
artificial light, later food intake and bedtimes. Food is a major synchronizer of peripheral circadian clocks, and 48 
delayed feeding due to prolonged night-time wakefulness leads to desynchrony between central circadian and 49 
peripheral clocks [4]. 50 
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Growing evidence points to an association between timing of food intake and obesity in humans, suggesting 51 
that changes in meal timing can influence obesity and success of weight loss therapy [1]. Also in animals, 52 
weight regulation is affected by the timing of food ingestion [5, 6]. 53 
On this basis, obesity could now represent a “chronobiological disease” [7]. Differently from the time-54 
restricted feeding pattern unintentionally practiced by our ancestors for thousands of years, the current trend 55 
is to shift most of the caloric intake later in the day [8]. In a few cross-sectional studies, an increased risk of 56 
overweight and obesity was found when a greater daily caloric intake was consumed in the evening [9-12], 57 
while a reduced risk was observed when consuming a larger proportion of calories at lunch or breakfast [9, 58 
11, 13]. 59 
Even though the association between evening eating and body weight was not confirmed in a prospective US 60 
cohort, it was present in specific subgroups (smoking men, physically active men, inactive women) [14]. 61 
Another prospective study showed that late-night eaters had an increased coronary heart disease risk [15]. 62 
The clinical relevance of meal timing appears to be supported by its role in weight loss strategies. In a 20-week 63 
intervention study, as compared with early lunch eaters, late lunch eaters lost less weight independently from 64 
self-reported 24-h caloric intakes [16]. In overweight and obese women with metabolic syndrome, a 12-week 65 
weight-loss program with high caloric breakfast was more effective in reducing weight and waist 66 
circumference than an isocaloric diet with high caloric intake at dinner [17]. 67 
Aside from body composition and weight regulation, timing of food intake seems to have a negative impact 68 
also on metabolism. Eating lunch later in the day was associated with poorer insulin sensitivity assessed by 69 
HOMA-IR (Homeostasis-Model Assessment-Insulin Resistance) index [16]. Experimental studies showed a 70 
higher decrease in HOMA-IR after a high caloric breakfast vs dinner in women with metabolic syndrome [17] 71 
and polycystic ovary syndrome [18]. Late lunch eating was associated with decreased pre-meal resting energy 72 
expenditure, lower pre-meal carbohydrate utilization, and decreased glucose tolerance after mixed-meal test 73 
[19]. In another study exploring food-induced thermogenesis in the morning and evening, the same meal 74 
consumed in the evening determined a lower after-meal resting metabolic rate and increased, delayed 75 
concentrations of glucose and insulin [20]. 76 
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These preliminary data suggest that consuming a larger proportion of total daily energy in the morning, as 77 
opposed to later in the day, might be more beneficial for weight loss.  78 
 79 
The aim of this study was to perform a systematic review of observational and experimental studies comparing 80 
the effect of different food timing on body weight and metabolic outcomes in adults. The possibility to 81 
undertake a meta-analysis of the effects of the interventions on at least some of the outcomes was evaluated 82 
too. 83 
 84 
2. Material and Methods 85 
This article is structured according to the preferred items for Systematic Reviews and Meta-Analyses (PRISMA) 86 
guideline [21]. 87 
 88 
2.1 Literature search strategy 89 
The following electronic databases were queried using a combination of search terms: PubMed (National 90 
Library of Medicine), Trip database and The Cochrane Library, until 01 March 2017. The construction of the 91 
search strategy was performed using database specific subject headings and keywords. The search terms 92 
included combinations of “timing meal” or “timing meals” or “timing of food” or “food timing”, and Body Mass 93 
Index (BMI), obesity, weight, hyperglycemia, glycemia, insulin, insulin-resistance and type 2 diabetes mellitus 94 
(free-term and MESH as possible) (Appendix 1). 95 
These search strategies were supplemented by hand searching the bibliographies of all the included studies. 96 
Searches were limited to randomized controlled trials, parallel or cross-over, and observational studies in 97 
healthy volunteers or patients (e.g. individuals with obesity/overweight, polycystic ovary syndrome, metabolic 98 
diseases or other underlying diseases). We excluded studies performed in children. 99 
 100 
2.2 Study selection 101 
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We included studies reporting comparisons of different timing meal interventions or habits (early eaters/late 102 
eaters or different timing of daily energy intake distribution) to reduce weight, insulinemic and glycemic areas-103 
under-the-curve values and other metabolic variables. 104 
Two review authors (SB, CM) independently scanned the abstract, title, or both, of every record retrieved, to 105 
determine which studies should be assessed further. All potentially relevant articles were investigated as full 106 
text. Any discrepancy about inclusion was resolved by discussing with a third review author (GB). 107 
 108 
2.3 Data collection and extraction 109 
For the trials that fulfilled the inclusion criteria, two authors independently abstracted key participant 110 
characteristics and reported data on efficacy outcomes using standard data extraction templates.  111 
From each included study, information was extracted on: 112 
 Characteristics of study participants (type of population, age, BMI); 113 
 Type of intervention; 114 
 Outcomes: 115 
 Anthropometric variables (BMI, weight, waist circumference, total body fat, etc.); 116 
 Metabolic variables (blood glucose values, triglycerides, total cholesterol, HDL and LDL-117 
cholesterol, etc.); 118 
 Hormonal variables (blood insulin, progesterone, testosterone, etc.); 119 
 Calorimetric variables (fasting or after-meal resting metabolic rate, fasting or after meal 120 
respiratory quotients, etc). 121 
 122 
2.4 Risk of bias assessment 123 
The validity of each study was independently assessed by two authors (SB, GB) using two tools: a) the 'Risk of 124 
bias' tool developed by The Cochrane Collaboration for RCT [22], and b) the 'Risk Of Bias in Non-randomized 125 
Studies of Interventions' (ROBINS-I) tool for evaluating risk of bias in estimates of the comparative 126 
effectiveness of interventions from studies not using randomization to allocate units (individuals or clusters of 127 
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individuals) to comparison groups [23]. As they were familiar with the literature, review authors were not 128 
blinded with respect to the study authors, institution or journal. We resolved possible disagreements by 129 
consensus, or with consultation with a third review author (AE). 130 
We could not undertake a meta-analysis of the effects of the interventions due to the great variability in 131 
outcome assessment and reporting, and in the type of interventions. 132 
 133 
3. Results 134 
3.1 Flow and characteristics of included studies 135 
With the initial literature search, 926 articles were found (Figure 1). Fifteen records were identified and 136 
carefully assessed for eligibility, after excluding non-original articles, duplicates, and articles not meeting the 137 
inclusion criteria. Only 10 studies satisfied all the inclusion criteria and were selected for the systematic review, 138 
including a total number of 6401 subjects (Table 1). The largest study recruited 4243 subjects [24] while the 139 
smallest one only 6 subjects [25]. Included studies were conducted in Spain [16, 19, 24, 26], Israel [17, 18], 140 
Japan [27], UK [25], and Italy [20, 28], between 2001-2014. Participants were: healthy individuals [19, 20, 25, 141 
27], general population [24, 28], overweight/obese subjects [16, 17], post-bariatric surgery patients [26], 142 
women with polycystic ovary syndrome [18]. In one case participants were paid [27]. The demographic and 143 
clinical characteristics of the included studies are shown in Table 1.  144 
Five of the included studies were trials: randomized cross-over [19, 20, 25, 27] and randomized controlled 145 
trials [17, 18], respectively, while four were observational prospective studies [16, 24, 26, 28]. The duration of 146 
the observational period was respectively: 6 years [26, 28], 3.5 years [24], and 20 weeks [16]. 147 
The interventions of the trials varied from the acute consumption of one or more meals a day at different 148 
hours [20, 25, 27] to early eating vs late eating the greater amount of kcal/day for 2 weeks [19] or 12 weeks 149 
[17, 18]. 150 
Observational studies divided participants according to the timing of the main meal (lunch before or after 151 
15:00) [16, 26], the timing of the consumption of the larger amount of calories [24] or the tertiles of the 152 
percentage of total daily caloric intake from dinner [28]. 153 
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The following outcomes were evaluated: variation on anthropometric variables [16-19, 24, 28], energy 154 
expenditure by indirect calorimetry [19, 20, 27] or equations [16, 26], metabolic parameters [16-20, 25-28], 155 
sleep pattern [16, 19, 26], body temperature [19], carbohydrate absorption [27], satiety [17], hormonal 156 
assessments [18, 19], and other blood variables, such as inflammatory parameters and liver enzymes [28]. 157 
 158 
3.2 Risk of bias assessment 159 
Most of the analyzed trials provided insufficient information about randomization procedures (Table 2). If 160 
blinding of participants was not feasible owing to the nature of the interventions, data about blinding of the 161 
personnel who performed the laboratory or statistical analyses was often unknown. In one study about 20% 162 
of participants dropped out [17]. Most trials appeared to be free of selective outcome reporting and of other 163 
sources of bias. 164 
The risk of bias for the observational studies is reported in Table 3. Most of the evaluated risks of bias were 165 
low/moderate. Ruiz-Lozano classified post-bariatric surgery patients by their weight-loss pattern after surgery 166 
and compared the timing of meals among groups [26]. The three groups, however, significantly differed for 167 
age and gender: older male patients were more frequently poor responders. Hermengildo studied the risk of 168 
weight gain by the distribution of energy intake throughout the day, but weight gain was self-reported both 169 
at baseline and at the end of the follow-up [24]. 170 
 171 
3.3 Effect of timing of food intake on changes in weight and other anthropometric parameters 172 
Observational studies showed that late lunch-eaters (after 15:00) were 2-fold more frequent in poor-weight 173 
loss responders to bariatric surgery, independent of dietary macronutrient composition [26]; the OR of gaining 174 
weight (>3kg) was 0.79 (95% CI 0-63-0.99), 0.82 (95% CI 0.64-1.04) and 0.62 (95% CI 0.47-0.80) respectively in 175 
the second, third and the highest quartile of percent energy intake at lunch, when compared to the lowest 176 
quartile, in a multivariate logistic regression analysis (p for trend=0.001) [24]; being in the highest tertile of 177 
daily percent caloric intake at dinner was significantly associated with an increased risk of incident obesity 178 
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(OR=2.33, 95%CI 1.17-4.65) [28]; late lunch eaters lost less weight than early lunch eaters (7.7 vs 9.9kg) after 179 
a 20-week weight-loss intervention [16]. 180 
Apart from two observational studies [24, 28], the nutritional composition of meals was not different between 181 
the groups of early or later-eaters. This finding strongly reinforces the role of meal timing on the studied 182 
outcomes. 183 
The evaluated randomized trials reported: a significantly higher weight loss in the “more calories at breakfast” 184 
group when compared to the “more calories at dinner” group (-8.7±1.4 vs -3.6±1.5 kg, p<0.001) after 12-weeks 185 
of a hypocaloric diet in overweight/obese women [17]; no significant change in weight between two groups 186 
with the same distribution of calories as above reported, after 12 weeks of a maintenance diet in women with 187 
the polycystic ovary syndrome. 188 
A few studies evaluated other indices of body fat [16-18]. No difference in waist circumference values and 189 
total body fat, as measured by bioelectrical impedance, were evident at baseline among early vs late lunch 190 
eaters, but these data were not available at follow-up [16]. Individual eating “more calories at breakfast” 191 
showed greater waist circumference reduction compared to the “more calories at dinner” group after a 192 
weight-loss 1400 kcal diet [17]; this difference was not confirmed after a 1800-kcal maintenance diet in women 193 
with polycystic ovary syndrome [18]. Only in 3 studies, waist circumference was described with the same 194 
methods and at the same time (baseline, follow-up); therefore, we could not undertake a meta-analysis 195 
because of the low number of individuals, not representative of the complete review [16-18]. 196 
 197 
3.4 Effects of timing of food intake on glucose and insulin blood values 198 
At baseline, late lunch eaters when compared to early lunch eaters showed increased values of Homeostasis 199 
Model Assessment-Insulin Resistance (HOMA-IR) index, but fasting glucose and insulin blood concentrations 200 
were similar between the two groups; no data at follow-up were available [16]. Individuals in the highest tertile 201 
of percent daily caloric intake at dinner showed an increase risk of incident type 2 diabetes (2.26; 95%CI 0.89-202 
5.75) [28]. 203 
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The trials evaluating the acute consumption of one or more meals/day reported that: a) glucose responses 204 
were greater after consuming the majority of energy load in the evening than in the morning, while insulin 205 
responses and post-prandial insulin resistance seemed to be mainly affected by the quality of carbohydrates 206 
[25]; b) the efficiency of digestion and absorption of dietary carbohydrates consumed at breakfast was higher 207 
if the previous supper was later (at 23:00) than under usual conditions (at 18:00) and, accordingly, after-208 
breakfast glucose values were increased until 3 hours in case of previous late suppertime [27]; c) the same 209 
meal consumed in the evening determined delayed and larger increases in glucose and insulin blood 210 
concentrations and significant increases in the corresponding areas-under-the curve [20]. 211 
The study protocol 1 of Bandin showed increased post-prandial glucose responses in late lunch eaters with a 212 
46% higher glucose area-under-the curve than in early lunch eaters [19]; women eating “more calories at 213 
breakfast” showed greater reduction in fasting glucose, insulin and insulin resistance evaluated by the HOMA-214 
IR index and, similarly, reduced glycemic and insulinemic responses both to the oral glucose tolerance test and 215 
to a meal challenge when compared to the “more calories at dinner”, after 12 weeks of isocaloric 1400-kcal 216 
diet [17]; in lean women with polycystic ovary syndrome, a high caloric intake at breakfast resulted in 217 
significantly reduced glucose and insulin areas-under-the-curve and an improvement in insulin sensitivity than 218 
consuming a high caloric intake at dinner [18].  219 
 220 
4. Discussion 221 
New, intriguing contributors to the epidemic of obesity have been lately recognized, such as meal frequency 222 
and patterns [29, 30], as well as sleep duration and quality [31]. Emerging evidence sounds the alarm on the 223 
role of meal timing and questions whether when to eat matters as much as what and how much to eat. 224 
Few cross-sectional studies tried to answer this question, finding that later timing of meals or eating more 225 
calories later in the day has a negative impact on body weight and metabolism [9-13]. 226 
Our systematic review of observational and experimental studies, including both healthy individuals [19, 20, 227 
24, 25, 27, 28] and patients with different dysmetabolic conditions [16-18, 26] confirms the health benefits of 228 
early eating, with positive effects on body weight, weight loss success, and glucose metabolism. 229 
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 230 
4.1 Timing of food intake and obesity 231 
Experimental studies show that animal models fed at unusual feeding time develop obesity, even without 232 
change in activity or total energy intake [5, 32]. High-fat meal at the end of the active phase leads to increased 233 
weight gain [33]. When challenged with a high-fat diet, chronodisrupted mice were more likely to be obese 234 
[34]. 235 
The pathophysiologic basis of these findings relies on the new definition of obesity as a chronobiological 236 
disease [7]. Unusual feeding time can represent a circadian disruption leading to clock gene functional 237 
alterations and uncoupling between the central and peripheral oscillators, circadian variations of peripheral 238 
clocks, gene expression, satiety hormones, and digestive processes [1]. Among mechanisms promoting 239 
obesity, diet-induced thermogenesis is lower at night [35], and the reduced thermic effect of glucose in obesity 240 
is likely related to the nocturnal insulin resistance [36]. Additionally, reduced fat oxidation has been observed 241 
during nighttime eating [37, 38]. 242 
Also in humans, cross-sectional studies suggest that eating time is relevant for obesity. Particularly, consuming 243 
a greater daily caloric in the evening is associated with higher risk of overweight and obesity [9-12], while 244 
eating more calories at lunch or breakfast appears to be protective against overweight/obesity [9, 11, 13]. 245 
The observational studies included in the present systematic review showed a positive association between 246 
meal timing and body weight [16, 24, 26, 28], that remained significant also after controlling for many 247 
counfunding factors involved in the obesity development, such as physical activity and sleep time [16, 24, 26, 248 
28]. Even though short sleep duration is a well know, independent risk factor for obesity, self-reported data 249 
on sleep time appear similar among the different weight loss patterns [16, 26] and therefore probably did not 250 
mediate the observed outcomes. The association between meal timing and body weight was supported also 251 
by a causal direction described in the included experimental studies [17-20, 25, 27]. Furthermore, the benefits 252 
were evident in a wide range of individuals: post-bariatric surgery patients [26], women with metabolic 253 
syndrome [17], overweight/obese subjects attending nutrition clinics [16, 26] and general population [24, 28]. 254 
Specifically, in post-bariatric surgery patients, left ventricular mass was decreased one year after procedure; 255 
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this improvement correlated only with the decrease in leptin levels [39], postulating a cardiovascular 256 
protection from weight loss also mediated by hormonal changes. 257 
This key message has a clear practice implication, and should be considered by clinicians when drawing up a 258 
nutritional scheme. 259 
 260 
4.2 Timing of food intake and hyperglycemia 261 
Circadian misalignment is known to result in adverse metabolic and cardiovascular consequences [40, 41]. 262 
Experimental studies explored the possible mechanisms supporting the circadian modulation of insulin 263 
secretion or action. Pathophysiological hypotheses of decreased insulin sensitivity later in the day [42] are 264 
represented by increased levels of triglycerides [43] and urinary epinephrine [44], fluctuation in cortisol serum 265 
concentrations [45] and higher morning ACTH plasma values [46], and/or a delayed peak in the counteracting 266 
activity of glucagon after evening meals [47]. Moreover, under late suppertime conditions, an increased 267 
efficacy of dietary carbohydrates absorption has been described [27]. Yet, increased evening meal emptying 268 
time seems to lead to evening delay in reaching peak plasma concentrations of the absorbed substances [48]. 269 
Metabolic consequences of experimental interventions occur rapidly and are already observed after an acute 270 
consumption of one or more meals a day at different hours [20, 25, 27]. 271 
 272 
4.3 Clinical prospective 273 
The success of weight loss therapy seems to be predicted by food timing; evening preference has a negative 274 
impact on metabolism, too. Even though not specifically design for food timing investigation, later chronotype 275 
individuals with type 2 diabetes, more likely characterized by later food ingestion, were characterized by a 276 
poorer glycemic control [49-52]. This observation raises the question whether meal timing intervention, with 277 
or without circadian phase changes, might be helpful in type 2 diabetes management; future studies are 278 
needed to verify this hypothesis. Indeed, The Academy of Nutrition and Dietetics has recently pointed up meal 279 
timing as a new potential target in weight control strategies [53], stating that consuming most of an 280 
individual’s energy earlier in the day may enhance weight loss and weight maintenance.  281 
12 
 
 
Among other clinical aspects of chronobiology in type 2 diabetes, it is worth considering that chronotherapy 282 
might apply not only to lifestyle but also to drug treatment. A prospective, randomized, open-label, blinded 283 
trial showed that blood pressure lowering drugs at bedtime reduced cardiovascular risk in type 2 diabetes 284 
patients with hypertension over a mean of 5.4 years, compared with the ingestion of drugs upon awakening 285 
[54]. Varying the time of day at which antihypertensive medications are taken is highly effective not only in 286 
diabetic but also non-diabetic subjects [55]. Like chronotherapy, also chronoprevention might apply to both 287 
lifestyle and drug treatment. In fact, in hypertensive patients without diabetes, administering ≥1 288 
antihypertensive medications at bedtime, particularly angiotensin receptor blockers and ACE inhibitors, 289 
compared with medications taken after awakening, reduced risk of incident diabetes during a 5.9-year median 290 
follow-up and improved blood pressure control with significant decrease of asleep blood pressure [56]. 291 
Another clinical application of food timing intervention might be represented by type 1 diabetes, even though 292 
it was not mentioned in the studies included in our systematic review. As type 1 diabetes in affected by 293 
increased mortality [57], it would be interesting to see whether optimal food timing and daily caloric 294 
distribution may improve short-term glycemic, endothelial dysfunction, inflammation and oxidative stress 295 
outcomes as cardiovascular risk markers. 296 
In consideration of the relevance of obesity- and type 2 diabetes- cardiovascular related diseases, it looks 297 
fundamental to search for efficient strategies for weight-loss and cardiovascular risk reduction. Future studies 298 
should verify whether well-known cardiovascular risk markers associated with obesity [39] and diabetes [58] 299 
may improve after chronotherapy intervention. 300 
 301 
4.4 Limitations 302 
The heterogeneity of the population studies and the evaluated outcomes has prevented us from performing 303 
a meta-analysis. The findings of the present systematic review do not allow to definitely prove the relationship 304 
between meal timing and the improvement of overweight and dysmetabolic conditions in humans. The 305 
heterogeneity of the included studies should be considered as a limitation, since either healthy individuals or 306 
patients with different dysmetabolic conditions have been enrolled. As another limitation, some studies 307 
13 
 
 
included in this analysis were not primarily designed to assess the effects of meal timing on weight or 308 
metabolic variables, suggesting a high risk of both publication and outcome reporting biases. The use of any 309 
drug was considered as exclusion criteria in most studies [16-20,27], but in 3 of the observational studies 310 
[24,26,28], data relative to pharmacological treatment were not reported; we therefore could not exclude 311 
that therapeutic regimens might have influenced weight loss dynamics or food intake timing in these studies. 312 
Finally, the number of trials and individuals included in the present review was small, which made it difficult 313 
to definitively assess the metabolic effect of meal timing, and required further investigations. 314 
Nevertheless, to the best of our knowledge, this is the first systematic review on this topic and could contribute 315 
to advancing knowledge and generating new studies in the field 316 
 317 
4.5 Conclusions 318 
Accumulating evidence summarized in this systematic review supports the negative impact of later meal 319 
timing and calories distribution on body weight and metabolism. High quality studies are needed to clarify the 320 
effectiveness of changes in eating time as an additional strategy for obesity and diabetes prevention and 321 
treatment in adults. 322 
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Table 1. Characteristics of the included studies 
Observational studies 
Author(year
) 
[ref] 
Methods Participants Intervention Outcomes Changes in outcomes 
Ruiz Lozano 
(2016) 
[26] 
Observational 
prospective 
study 
(2006-2011) 
N=270 patients treated 
with bariatric surgery 
(Roux-en-Y gastric 
bypass and sleeve 
gastrectomy) 
 
Early eating vs Late eating 
according to the timing of 
main meal (before and after 
15.00) 
Anthropometry measures: weight, BMI, 
postoperative weight loss 
Energy and dietary intake before/during/after 
bariatric surgery: 4-days food record 
Morningness/eveningness questionnaire 
Weight change: 70% of 
late eaters in poor 
weight-loss responders 
vs 42% in secondarily 
poor weight-loss 
responders and 37% in 
good weight-loss 
responders (p=0.01) 
Hermenegild
o Y (2016) 
[24] 
Observational 
prospective 
study 
(2008-2012)  
N=4243 adults from a 
population-based 
cohort 
Inclusion criteria: ≥18y, 
living in Spain, alive at 
follow-up 
Exclusion criteria: 
institutionalized, 
unable to give valid 
data about diet, cases 
with missing data on 
the evaluated variables 
Quartile of energy intake by 
different meals (breakfast, 
mid-morning meal, lunch, 
mid-afternoon meal, 
dinner, snacking) 
Anthropometry measures: weight gain (>3 kg) Weight change: compared 
with those in the lowest 
quartile of % energy 
intake at lunch, the 
multivariate OR of 
gaining >3kg was 0.79 
(95% CI 0.63-0.99) in the 
second quartile, 0.82 
(0.64-1.04) in the third 
quartile and 0.62 (0.47-
0.80) in the highest 
quartile (Ptrend=0.001) 
Bo S 
(2014) 
Observational N=1245 adults from a 
population-based 
cohort 
Tertiles of the percentage of 
total daily caloric intake 
from dinner 
Anthropometric measures: weight, height, BMI, 
waist circumference 
Incidence of obesity: from 
the lowest to the highest 
tertiles of total % daily 
caloric intake at dinner, 
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[28] prospective 
study 
(2001-2008) 
Inclusion criteria: age 
45-64y from 6 general 
practitioners, 
Caucasian, living in Asti 
(North-Western Italy) 
Exclusion criteria: 
obesity and/or 
diabetes mellitus at 
baseline, died during 
follow-up 
Metabolic parameters:  blood glucose, glycated 
hemoglobin, cholesterol, HDL-cholesterol, 
LDL-cholesterol, triglycerides, HOMA-IR index 
Other blood parameters: C-reactive protein, 
alanine aminotransferase, γ-glutamyl 
transferase 
the incidence rate of 
obesity increased (from 
4.7 to 11.4%, p<0.01). 
The increased obesity 
risk for subjects in the 
highest tertile was 
confirmed in a multiple 
regression model 
(OR=2.33; 95% CI 1.17–
4.65; p=0.02). 
Incidence of diabetes: 
individuals in the highest 
tertile of dinner % daily 
caloric intake showed an 
increase risk of incident 
type 2 diabetes (2.26; 
0.89-5.75) 
Garaulet M 
(2013) 
[16] 
Observational 
prospective 
study  
(2007-2008)  
N=420 
obese/overweight 
individuals 
Exclusion criteria: 
special diet, weight-
loss drugs, diabetes 
mellitus, chronic renal 
failure, hepatic 
diseases, cancers, any 
nutrition program 
within 2-y 
Early eaters (lunch before 
15:00) and late eaters 
(lunch after 15:00)  
All subjects received a 60-
min educative program 
(once/week) with 
nutritional and exercise 
recommendations and a 
cognitive-behavioral 
approach 
 
Anthropometric measures: weight, height, 
BMI, total body fat, waist circumference 
Metabolic parameters:  blood glucose, 
cholesterol, HDL-cholesterol, LDL-cholesterol, 
triglycerides, HOMA-IR index, leptin, ghrelin 
Energy intake before/during treatment: 1-day 
dietary recall 
Energy expenditure: estimated by equations 
Morningness/eveningness questionnaire 
Sleep duration: evaluated by questionnaire  
Weight change: early 
lunch eaters lost more 
weight than late eaters 
during the 20-weeks of 
intervention (9.9±5.8 vs 
7.7±6.1 kg, p=0.008). The 
weight loss, expressed as 
% of initial weight was 
respectively: 11.3±5.8 vs 
9.0±7.1 (p=0.006) 
Randomized cross over/ controlled studies 
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Author(year
) 
[ref] 
Methods Participants Intervention Outcomes Changes in outcomes 
Bo S (2015) 
[20] 
 
Cross-over 
randomized 
trial 
 
N=20 healthy 
volunteers 
Inclusion criteria: age 
20-35y, BMI 19-26 
kg/m2, habitual 
moderate exercise 
level, <10 
cigarettes/day. 
Exclusion criteria: Any 
acute or chronic 
diseases, menopause, 
any drugs or 
supplementations, any 
alimentary restrictions 
or specific diets, being 
a shift or night 
workers, unable to give 
a written informed 
consent 
The same meal at 8:00 and, 
7 days after at 20:00 or vice 
versa 
Each experiment lasted 
about 2-h 
Calorimetric evaluation: fasting RMR, after-
meal RMR, DIT, fasting RQ, after meal RQ, RQ 
difference 
Metabolic parameters: blood glucose, insulin, 
FFA, triglycerides every 30 min after each 
meal for 180 min 
 
Metabolic variables: 
delayed and larger 
increases in glucose and 
insulin concentrations 
were found after the 
evening meals. 
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Bandin C 
(2015) 
[19] 
Cross-over 
randomized 
trial 
 
Protocol 1 
Each 
experiment 
lasted 2 weeks, 
after 1 week 
wash out 
Protocol 2 
Each 
experiment 
lasted 2 weeks, 
after 1 week 
wash out 
N=32 healthy women 
Exclusion criteria: 
endocrine, renal, 
hepatic, psychiatric 
disorders, any drugs 
(other than oral 
contraceptives) 
 
Protocol 1: N=10 
Protocol 2: N=22 
Early eating (lunch at 
13:00) vs late eating (lunch 
at 16:30) for 2 weeks. 
 
Specific measurements to protocols: 
Protocol 1 
Calorimetric evaluation:  fasting RMR, after-
meal RMR, fasting RQ, 
after meal RQ, carbohydrate oxidation  
Metabolic parameters: Mixed meal test for 
glucose tolerance  
Protocol 2 
Wrist temperature 
Hormonal assessments: salivary cortisol 
Metabolic variables: late-
eating lunch individuals 
showed significantly 
increased post-prandial 
glucose areas-under-the-
curve than early eaters 
(102.6±30.8 vs 70.0±32.9 
mmol/l×h; p=0.002) 
Jacubowitz 
D,a (2013) 
[17] 
Randomized 
controlled trial 
N=93 overweight and 
obese women. 
Inclusion criteria: age 
20-65y, BMI 25-37 
kg/m2, non-diabetic 
OGTT, presence of the 
metabolic syndrome 
Exclusion criteria: 
abnormal thyroid, liver 
or kidney function, 
cardiovascular disease, 
Subjects were randomized 
to one of the following 
1400 kcal weight-loss diet 
for 12 weeks:  
-breakfast group (700 kcal 
breakfast, 500 kcal lunch, 
200 kcal dinner; N=46) 
-dinner group (200 kcal 
breakfast, 500 kcal lunch, 
700 kcal dinner; N=47)  
Anthropometric measures: height, weight, BMI, 
waist circumference 
Metabolic parameters: blood glucose and 
insulin after an OGTT, total cholesterol, LDL-
cholesterol, HDL-cholesterol, triglycerides, 
ghrelin, HOMA-IR and HOMA-b, ISI  
Appetite: evaluated by questionnaires 
 
Weight change: the 
breakfast group showed 
the greater weight loss 
after the intervention  
(-8.7±1.4 vs -3.6±1.5 kg;  
p<0.001) 
Metabolic variables: % 
changes in fasting glucose 
(-11.5 vs -4.2%), insulin  
(-51 vs -29%) and HOMA-IR 
(-57 vs -32.5%) significantly 
25 
 
 
cancer, hypoglycemic 
drugs  
decreased in the breakfast 
group. Similarly, OGTT test 
led to a greater decrease 
of glucose and insulin in 
the breakfast group  
Jacubowitz 
D,b (2013) 
[18] 
Randomized 
controlled trial 
N=60 women with 
polycystic ovary 
syndrome 
Exclusion criteria: 
BMI>24.9 kg/m2, on 
any diet, any drugs 
affecting weight, 
changing in weight >4.5 
kg or in physical 
activity within the last 
6 months 
Subjects were randomized 
to one of the following 
1800 kcal maintenance diet 
for 12 weeks:  
-breakfast diet (980 kcal 
breakfast, 640 kcal lunch, 
190 kcal dinner; N=29) 
-dinner diet (190 kcal 
breakfast, 640 kcal lunch; 
980 kcal dinner; N=31)  
Anthropometry measures: BMI, waist 
circumference 
Metabolic parameters:  blood glucose, insulin, 
HOMA-IR, HOMA-b 
Hormonal assessments: blood progesterone 
level, free and total testosterone, SHBG, 17-OH 
estradiol, DHEA-S, 17OHP, FAI, leuprolide 
stimulation test 
Weight change: after the 
maintenance diets, 
weights did not change in 
the breakfast and dinner 
groups  
 
Metabolic variables: in 
the breakfast group, % 
changes of fasting glucose 
(-8 vs +2%), fasting 
insulin (-53 vs 0%), 
HOMA-IR (-56 vs +1%), 
HOMA-b (-35 vs -7%), ISI 
(+135 vs +2%), and 
glucose (-20 vs 0%) and 
insulin (-49 vs -7%) 
areas-under-the-curve 
were significantly higher 
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Morgan LM 
(2012) 
[25] 
Cross-over 
randomized 
trial 
 
N=6 healty volunteers  Subjects were randomized 
to one of the following 
2000 kcal diets by cross-
over: 
-Low glycemic index with 
big breakfast (1200 kcal) 
and small dinner (400 kcal) 
-Low glycemic index with 
big dinner (1200 kcal) and 
small breakfast (400 kcal) 
-High glycemic index with 
big breakfast (1200 kcal) 
and small dinner (400 kcal) 
-High glycemic index with 
big dinner (1200 kcal) and 
small breakfast (400 kcal) 
Metabolic parameters:  Blood glucose and 
insulin every 30 min after each meal for 120 
min, post-prandial HOMA-IR, interstitial 
glucose by a continuous glucose monitoring 
system applied the day before each test 
Metabolic variables: 
interstitial glucose and 
insulin areas-under-the 
curve were significantly 
higher after consuming a 
big dinner rather than a 
big breakfast at the same 
glycemic index 
Tsuchida Y 
(2013) 
[27] 
Cross-over 
random trial  
12 females (paid 
participants) 
Inclusion criteria: 
university students 
Exclusion criteria: 
smoking, current 
antibiotic use 
Two experimental 
conditions:  
a meal at usual suppertime 
(18:00) 
a meal at late suppertime 
(at 23:00), performed in 
different days 
 
Metabolic parameters: blood glucose every 30 
min after each supper and after the breakfast 
of the next day for 180 min, unabsorbed 
carbohydrates by breath hydrogen test 
Calorimetric evaluation: RQ 
Metabolic variables: a late 
suppertime meal 
determined significantly 
increased glucose values 
at 30, 60, 120, 150 and 
180-min after the 
breakfast consumed the 
day after, with respect to 
the usual suppertime 
meal 
Abbreviations: 17-alpha Hydroxyprogesterone (17OHP), Body Mass Index (BMI), Dehydroepiandrosterone-Sulfate (DHEA-S), Diet-Induced Thermogenesis (DIT), 
Free Androgen Index (FAI), High Density Lipoprotein (HDL), Homeostasis model Assessment-Insulin resistance (HOMA-IR), Homeostasis model Assessment-beta 
cell function (HOMA-b), Insulin Sensitivity Index (ISI), Low Density Lipoprotein (LDL), Oral Glucose Tolerance Test (OGTT), Respiratory Quotient (RQ), Resting 
Metabolic Rate (RMR), Sex Hormone-Binding Globulin (SHBG). 
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Table 2 Risk of bias assessment in the trials included in the systematic review 
Study Random 
sequence 
generation 
Allocation 
concealment 
Blinding Incomplete outcome data Selective reporting Free of other bias 
Bo (2015) L U L L L L 
Bandin (2015) L U U L L U 
Jacubowitza (2013) U U H H L L 
Jacubowitzb (2013) U U U L L L 
Tsuchida (2013) U U U U L L 
Morgan (2012) U U U L L U 
 
Criteria defined for quality assessment are based on the Cochrane guidelines. 
Abbreviations: H, high risk of bias; L low risk of bias; U unclear or unrevealed risk of bias 
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Table 3 Risk of bias assessment in the observational studies included in the systematic review 
 
Study Ruiz Lozano (2016) Hermenegildo (2016) Bo 
(2014) 
Garaulet 
 (2013) 
Domain     
Bias due to confounding Serious Moderate Moderate Moderate 
Bias in selection of participants into study Moderate Low Moderate Moderate 
Bias in classification of interventions Moderate Moderate Moderate Moderate 
Bias due to departure from intended 
interventions 
Low Low Low Low 
Bias due to missing data Moderate Low Low Low 
Bias in measurement of outcomes Low Serious Low Low 
Bias in selection of the reported results Moderate Low Low Moderate 
Overall* Serious Serious Moderate Moderate 
*Overall assessment derived from the seven domains of ROBINS-I (Risk Of Bias In Non-randomized Studies -of Intervention scale) tool  
 
 
